Strategic Partners A/S (CPSE: STRAP)
Health Care · Biotechnology · DK
Dkr700.00
-6.04% today · -32.7% 1Y
Strategic Partners A/S (CPSE: STRAP) operates in the Biotechnology industry within the Health Care sector. The company is valued at $4.56M and employs 1 people.
Over the last twelve months the share price has lost 32.7%, trading between 515.00 and 1.04K.
Tweenvest scores Strategic Partners A/S across four factors: quality 43/100, value 50/100. Its strongest factor is value.
STRAP price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $4.56M
- Revenue (TTM)
- $46.45K
- P/E
- 21.97
- EPS
- 31.86
- Dividend yield
- —
- Beta (5Y)
- 0.28
- 52-week high
- Dkr1,045.00
- 52-week low
- Dkr515.00
- Avg volume (3M)
- —
- Shares outstanding
- 41.71K
- Employees
- 1
- Next earnings
- —
About Strategic Partners A/S
Strategic Partners A/S currently conducts minimal business operations. Its previous activities centered on the field of biotechnology. The firm, originally known as Orphazyme A/S, adopted the new moniker Strategic Partners A/S in October 2024. Established in 2009, the company's base of operations is situated in Herlev, Denmark.
- ISIN
- DK0062502894
- Founded
- 2009
- Listed since
- Nov 21, 2017
- Exchange
- OMX Nordic Exchange Copenhagen
- Currency
- DKK
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| AbbVie Inc.NYSE: ABBV | $468.22B | $264.96 | +1.20% |
| Amgen Inc.NasdaqGS: AMGN | $237.52B | $439.33 | +1.29% |
| Gilead Sciences, Inc.NasdaqGS: GILD | $181.18B | $146.97 | +0.58% |
| Vertex Pharmaceuticals IncorporatedNasdaqGS: VRTX | $138.91B | $548.05 | +1.44% |
| Regeneron Pharmaceuticals, Inc.NasdaqGS: REGN | $83.28B | $834.04 | +0.90% |
| argenx SEENXTBR: ARGX | $65.85B | €883.80 | -2.02% |
| Moderna, Inc.NasdaqGS: MRNA | $57.92B | $142.92 | -1.48% |
| CSL LimitedASX: CSL | $57.77B | AU$168.30 | -1.69% |
Figures last refreshed Aug 18, 2026.